Ability to support suspension and stationary hybridomas and myelomas
Suitable for the culture of recombinant myeloma lines as well as traditional hybridomas, Gibco PFHM II provides high cell densities and IgG production. Cholesterol-dependent cultures such as NS0 require the addition of 250x Cholesterol Lipid Concentrate.

Complete, ready-to-use formulation：
Once reconstituted, Gibco PFHM II is a complete medium that is ready-to-use. No supplementation is required.

Serum-free, very low-protein formulation：
Gibco PFHM II is a serum-free, protein-free formulation, allowing for easier purification of your protein of interest.

Product Use：
For Research Use Only. Not for use in diagnostic procedures.

cGMP Manufacturing and Quality System：
Gibco PFHM II is manufactured at a cGMP compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.